The CooperCOO +4.04%85 Net Margin % is -7.20% as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 85/100 and a GF Value™ of $100.85 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, The Cooper ranks better than 60.59% on this metric.
Net margin is calculated as Net Income divided by its Revenue. The Cooper's Net Income for the
three
months ended in Apr. 2026 was $-78 Mil. The Cooper's Revenue for the
three
months ended in Apr. 2026 was $1,082 Mil. Therefore, The Cooper's net margin for the quarter that ended in Apr. 2026 was -7.20%.
The historical rank and industry rank for The Cooper's Net Margin % or its related term are showing as below:
COO'
s Net Margin % Range Over the Past 10 Years
Min: 5.52 Med: 10.87 Max: 100.76
Current: 5.57
COO's Net Margin % is ranked better than 60.59% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs COO: 5.57
The Cooper (NAS:COO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
The Cooper Net Margin % Related Terms
The Cooper Net Margin % Historical Data
* Premium members only.
The historical data trend for The Cooper's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Net Margin % distribution charts can be found below:
* The bar in red indicates where The Cooper's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (COO) has a Net Margin % of -7.20% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on The Cooper and its competitors. Over the past decade, The Cooper's Net Margin % has ranged from 5.52 to 100.76. According to the industry distribution chart, The Cooper ranks #322 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 39.4%.
Is The Cooper's Net Margin % too high?
The Cooper's current Net Margin % is -7.20%. Over the past 10 years, this metric has ranged from a low of 5.52 to a high of 100.76. Based on the distribution chart, The Cooper ranks #322 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, The Cooper has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Net Margin % compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, The Cooper ranks #322 out of 817 companies for Net Margin %. This puts The Cooper in the upper half of its industry. The industry median Net Margin % is 2.07. Historically, The Cooper's own Net Margin % has ranged from 5.52 to 100.76 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on The Cooper and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cooper's current Net Margin % is -7.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.85, compared to a current price of $68.83 — trading 31.8% below its estimated fair value. The current Net Margin % is -7.20%. The Cooper's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For The Cooper (COO), the current Net Margin % is -7.20% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $68.83 is trading 31.8% below its estimated GF Value™ of $100.85.
GuruFocus considers The Cooper to be Significantly Undervalued.
Key valuation signals for COO:
Net Margin %: -7.20%
GF Value™: $100.85 vs. price of $68.83 (31.8% below fair value)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
85GF Score
Get the complete analysis for COO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
